The Oncologist® is dedicated to translating the latest research developments into the best multidimensional care for cancer patients. Thus, The Oncologist is committed to helping physicians excel in this ever-expanding environment through the publication of timely reviews, original studies, and commentaries on important developments. We believe that the practice of oncology requires both an understanding of a range of disciplines encompassing basic science related to cancer, translational research, and clinical practice, but also the socioeconomic and psychosocial factors that determine access to care and quality of life and function following cancer treatment.
肿瘤学家®致力于将最新的研究进展转化为癌症患者的最佳多维护理。因此，《肿瘤学家》致力于通过及时发表评论、原创研究和对重要发展的评论，帮助医生在这个不断扩大的环境中脱颖而出。我们认为，肿瘤学实践不仅需要了解一系列学科，包括与癌症相关的基础科学、转化研究和临床实践，还需要了解决定癌症治疗后获得护理以及生活质量和功能的社会经济和心理社会因素。
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0356
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0433
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0785
10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.
来源期刊：The oncologistDOI：10.1634/theoncologist.2017-0577
The Role of Radiation Oncology in Immuno‐Oncology
来源期刊：The OncologistDOI：10.1634/theoncologist.2019-IO-S1-s04
Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow‐Up Care and Treatment: Perspectives of Human Immunodeficiency Virus‐Positive Women and Health Care Practitioners in Tanzania
来源期刊：The OncologistDOI：10.1634/theoncologist.2017-0444
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
来源期刊：The OncologistDOI：10.1634/theoncologist.2019-0608
The Development of an International Oncofertility Competency Framework: A Model to Increase Oncofertility Implementation.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0043
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0129
Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0040
Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0406
Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0305
Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0184
The Role of Primary Care Physicians in Childhood Cancer Survivorship Care: Multiperspective Interviews.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0103
Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial
来源期刊：The OncologistDOI：10.1634/theoncologist.2019-0262
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0510
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer
来源期刊：The OncologistDOI：10.1634/theoncologist.2018-0452
Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
来源期刊：The OncologistDOI：10.1634/theoncologist.2018-0740
Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0370
Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Practical Implications for the Community Oncologist.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0395
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0427
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0423
Sorafenib for Patients with Hepatocellular Carcinoma and Child‐Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study
来源期刊：The OncologistDOI：10.1634/theoncologist.2019-0718
Association of Age with Efficacy of Immunotherapy in Metastatic Melanoma.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0377
Pathological Response to Neoadjuvant Chemotherapy and the Molecular Classification of Locally Advanced Breast Cancer in a Latin American Cohort
来源期刊：The OncologistDOI：10.1634/theoncologist.2019-0300
Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0675
S‐1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial
来源期刊：The OncologistDOI：10.1634/theoncologist.2018-0901
Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0370
Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0641
18F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with 18F-FDG PET/CT.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0096
Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0493
The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon Cancer.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0469
Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0606
Integration of Tumor‐Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies
来源期刊：The OncologistDOI：10.1634/theoncologist.2017-0603
Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205).
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0750
Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0167
A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer.
来源期刊：The oncologistDOI：10.1634/theoncologist.2017-0664
Twenty-Five Years of The Oncologist.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0883
A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction
来源期刊：The OncologistDOI：10.1634/theoncologist.2018-0336
Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0451
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0403
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors
来源期刊：The OncologistDOI：10.1634/theoncologist.2018-0749
Cost and Utilization of Lung Cancer End-of-Life Care Among Racial-Ethnic Minority Groups in the United States.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0303
Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0063
Reflecting on the Human Connection.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0078
Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine Tumors.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0798
The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
来源期刊：The OncologistDOI：10.1634/theoncologist.2018-0528
Premature Termination of a Randomized Controlled Trial on Image-Guided Stereotactic Body Radiotherapy of Metastatic Spinal Cord Compression.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0672
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
来源期刊：The oncologistDOI：10.1634/theoncologist.2019-0172
Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study.
来源期刊：The oncologistDOI：10.1634/theoncologist.2018-0520
